DRIEHAUS CAPITAL MANAGEMENT LLC 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-14 09:42 am Sale | 2021-12-31 | 13G | Cytokinetics, Incorporated CYTK | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,327,112 2.770% | -712,144![]() (-23.43%) | Filing |